Archive · 6 Aug 2026
Molbio Diagnostics Announces Rs 940 Crore IPO from August 10
Molbio Diagnostics is a company that makes tests to find diseases quickly.
The company is based in Goa, a state in India.
It has announced that it wants to raise money by selling parts of itself, called shares.
This is known as an IPO, or initial public offering.
Molbio hopes to raise 940 crore rupees, which is a very large amount of money.
Each share will cost between 768 and 807 rupees.
People can start buying these shares on August 10, 2026.
The offer will close on August 12, 2026.
The company will use the money to build a new research laboratory and buy new machines.
Some money will also go to its work in Goa and Visakhapatnam.
Goa-based Molbio Diagnostics announced a Rs 940 crore initial public offering.
The IPO price band is Rs 768 to Rs 807 per equity share of Rs 1 face value.
The public issue opens on August 10 and closes on August 12, 2026.
The issue includes a fresh issue of Rs 200 crore and an offer for sale of Rs 740 crore.
Proceeds will fund R&D infrastructure and plant and machinery for its Goa and Visakhapatnam units.
- Who
- Molbio Diagnostics, a Goa-based molecular diagnostics company.
- What
- Announced a Rs 940 crore initial public offering (IPO) with a fresh issue and an offer for sale.
- When
- The issue opens on August 10, 2026 and closes on August 12, 2026.
- Where
- India, with funds earmarked for the company's Goa and Visakhapatnam units.
- Why
- To raise funds for R&D infrastructure, purchase of plant and machinery, and general corporate purposes.
- Company
- Molbio Diagnostics
- Headquarters
- Goa
- IPO Size
- Rs 940 crore
- Price Band
- Rs 768 - Rs 807 per share
- Face Value
- Rs 1 per share
- Fresh Issue
- Rs 200 crore
- Offer for Sale
- Rs 740 crore
- Subscription Dates
- August 10-12, 2026